VRNA vs. GDE

Last updated Jun 5, 2026

VRNA (Verona Pharma plc) is a stock, while GDE (WisdomTree Efficient Gold Plus Equity Strategy Fund) is Gold fund actively managed by WisdomTree. At a 0.20 correlation, their price movements are largely independent.

Performance

VRNA vs. GDE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

GDE

• 1D: 1.33%
• 1M: 2.08%
• YTD: 11.25%
• 6M: 13.51%
• 1Y: 54.50%
• 3Y*: 47.08%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. GDE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	430.02%
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund	11.25%	73.76%	44.79%	33.85%	-18.67%

Correlation

The correlation between VRNA and GDE is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (All Time) Calculated using the full available price history since Mar 18, 2022	0.20

The correlation between VRNA and GDE shifts across timeframes, from 0.06 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Return for Risk

VRNA vs. GDE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GDE

GDE Risk / Return Rank: 52
GDE Sharpe Ratio Rank: 58
GDE Sortino Ratio Rank: 49
GDE Omega Ratio Rank: 58
GDE Calmar Ratio Rank: 50
GDE Martin Ratio Rank: 46

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. GDE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and WisdomTree Efficient Gold Plus Equity Strategy Fund (GDE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VRNA	GDE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.93	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	1.17	—

Drawdowns

Drawdown Indicators

	VRNA	GDE	Difference
Max Drawdown Largest peak-to-trough decline	—	-32.01%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-22.66%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-22.66%	—
Current Drawdown Current decline from peak	—	-9.99%	—
Average Drawdown Average peak-to-trough decline	—	-7.89%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	7.29%	—

Volatility

Volatility by Period

	VRNA	GDE	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.68%	—
Volatility (6M) Calculated over the trailing 6-month period	—	24.27%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	28.41%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	26.12%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	26.12%	—

Dividends

VRNA vs. GDE - Dividend Comparison

VRNA has not paid dividends to shareholders, while GDE's dividend yield for the trailing twelve months is around 3.88%.

Position	TTM	2025	2024	2023	2022
GDE WisdomTree Efficient Gold Plus Equity Strategy Fund	3.88%	4.32%	7.14%	2.22%	0.81%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VRNA and GDE in my portfolio?

VRNA and GDE have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.